Interstitial Lung Diseases

This page lists the latest material on Interstitial Lung Diseases.

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era Gizal Nakshbandi, Catharina C. Moor, Kerri A. Johannson, Toby M. Maher, Michael Kreuter, Marlies S. Wijsenbeek ERJ Open Res, 7 (3) 00405-2021; 10.1183/23120541.00405-2021
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study Joanna C. Porter, Thida Win, Kjell Erlandsson, Francesco Fraioli, Alaleh Rashidnasab, Beverley Holman, Balaji Ganeshan, Nicholas J. Screaton, Toby M. Maher, Raymond Endozo, John Hoath, Robert I. Shortman, Elise Emond, Kris Thielemans, Brian F. Hutton, Pauline T. Lukey, Franklin Aigbirhio, Saif Khan, Manuel Rodriguez-Justo, Ashley M. Groves Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
COVID-19 pneumonia and the pulmonary vasculature: a marriage made in hell Peter M. George, Sujal R. Desai Eur Respir J, 58 (3) 2100811; 10.1183/13993003.00811-2021
Histopathology of newborn lung disease Michael T. Ashworth, J. Ciaran Hutchinson, Mohammad Haini Eur Respir Monogr 2021; 92: 287-300
Interstitial lung diseases in the neonatal period Yohan Soreze, Chiara Sileo, Aurore Coulomb l'Hermine, Marie Legendre, Nadia Nathan Eur Respir Monogr 2021; 92: 213-230
In utero and post-natal development of the human lung and its defence mechanisms Daniel T. Swarr, Hitesh Deshmukh, William Zacharias Eur Respir Monogr 2021; 92: 1-20
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema An Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, Mark G. Jones, Coline van Moorsel, Tamera J. Corte, Chiara Romei, Recep Savas, Christopher J. Brereton, Hendrik W. van Es, Helen Jo, Annalisa De Liperi, Omer Unat, Katarina Pontoppidan, Frouke van Beek, Marcel Veltkamp, Peter Hopkins, Yuben Moodley, Alessandro Taliani, Laura Tavanti, Bahareh Gholipour, Arjun Nair, Sam Janes, Iain Stewart, David Barber, Daniel C. Alexander, Athol U. Wells, Joseph Jacob ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021
Lung ultrasound assessment for pneumothorax following transbronchial lung cryobiopsy Christian B. Laursen, Pia I. Pietersen, Niels Jacobsen, Casper Falster, Amanda D. Juul, Jesper R. Davidsen ERJ Open Res, 7 (3) 00045-2021; 10.1183/23120541.00045-2021
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment Clara Hjalmarsson, Barbro Kjellström, Kjell Jansson, Magnus Nisell, David Kylhammar, Mohammad Kavianipour, Göran Rådegran, Stefan Söderberg, Gerhard Wikström, Dirk M. Wuttge, Roger Hesselstrand ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients Stine Johnsen, Stefan M. Sattler, Kamilla Woznica Miskowiak, Keerthana Kunalan, Alan Victor, Lars Pedersen, Helle Frost Andreassen, Barbara Jolanta Jørgensen, Hanne Heebøll, Michael Brun Andersen, Lisbeth Marner, Carsten Hædersdal, Henrik Hansen, Sisse Bolm Ditlev, Celeste Porsbjerg, Thérèse S. Lapperre ERJ Open Res, 7 (3) 00205-2021; 10.1183/23120541.00205-2021
Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis Osamu Nishiyama, Kensuke Kataoka, Masahiko Ando, Shinichi Arizono, Akira Morino, Koichi Nishimura, Tomoya Ogawa, Akira Shiraki, Fumiko Watanabe, Ryo Kozu, Takashi Ogura, Yasuhiro Kondoh ERJ Open Res, 7 (3) 00321-2021; 10.1183/23120541.00321-2021
Risk factors associated with the development of interstitial lung abnormalities Ivette Buendía-Roldán, Rosario Fernandez, Mayra Mejía, Fortunato Juarez, Gustavo Ramirez-Martinez, Eduardo Montes, Ana Karem S. Pruneda, Karen Martinez-Espinosa, Aime Alarcon-Dionet, Iliana Herrera, Carina Becerril, Leslie Chavez-Galan, Mario Preciado, Annie Pardo, Moisés Selman Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020
ERS guidelines on treatment of sarcoidosis D. Valeyre (Paris, France), Robert P. Baughman (Cincinnati, USA), P. Korsten (Göttingen, Germany) Wednesday, 23 June 2021
Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD E. Bargagli, (Siena, Italy), E. Renzoni (London, United Kingdom), O. Distler (Zurich, Switzerland), K. Antoniou (Heraklion, Greece), B. Crestani (Paris, France) Monday, 14 June 2021
Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Manuela Platé, Yoshihiko Kobayashi, Rachel C. Chambers, Purushothama Rao Tata Eur Respir Monogr 2021; 91: 290-305
Evidence for the involvement of lipofibroblasts, airway smooth muscle cells and FGF10 signalling in lung repair Elie El Agha, Saverio Bellusci Eur Respir Monogr 2021; 91: 99-113
Natural variability in the disease course of SSc-ILD: implications for treatment Madelon C. Vonk, Ulrich A. Walker, Elizabeth R. Volkmann, Michael Kreuter, Sindhu R. Johnson, Yannick Allanore Eur Respir Rev, 30 (159) 200340; 10.1183/16000617.0340-2020
Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study Sebastian Majewski, Xingwu Zhou, Joanna Milkowska-Dymanowska, Adam J. Bialas, Wojciech J. Piotrowski, Andrei Malinovschi ERJ Open Res, 7 (1) 00489-2020; 10.1183/23120541.00489-2020
Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis Sang-Hun Kim, Jung Yeon Lee, Chang Min Yoon, Hyeon Jun Shin, Sei Won Lee, Ivan Rosas, Erica Herzog, Charles S. Dela Cruz, Naftali Kaminski, Min-Jong Kang Eur Respir J, 57 (4) 2000652; 10.1183/13993003.00652-2020
Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort Raphael Lhote, Isabella Annesi-Maesano, Hilario Nunes, David Launay, Raphael Borie, Karim Sacré, Nicolas Schleinitz, Mohamed Hamidou, Matthieu Mahevas, Hervé Devilliers, Philippe Bonniaud, François Lhote, Julien Haroche, Pierre Rufat, Zahir Amoura, Dominique Valeyre, Fleur Cohen Aubart Eur Respir J, 57 (4) 2001160; 10.1183/13993003.01160-2020
MAV(S)erick mitochondria: an unconventional role for mitochondrial antiviral signalling protein in pulmonary fibrosis Ram P. Naikawadi, Paul J. Wolters Eur Respir J, 57 (4) 2004500; 10.1183/13993003.04500-2020
Reply: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Jürgen Behr, David Pittrow, Jens Klotsche Eur Respir J, 57 (3) 2100283; 10.1183/13993003.00283-2021
Comment on: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Jakob Borchardt Eur Respir J, 57 (3) 2004645; 10.1183/13993003.04645-2020
Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias? Samy Suissa, Deborah Assayag Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020
Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study Amir M. Hasani, Brianna Matthew, Mahshid Goljamali, Yun-Ching Chen, Mario Stylianou, Mehdi Pirooznia, Angelo Taveira-DaSilva, Marcus Y. Chen, Han Wen, Joel Moss Eur Respir J, 57 (3) 2003769; 10.1183/13993003.03769-2020
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation Spyros A. Papiris, Demosthenes Bouros, Katerina Markopoulou, Lykourgos Kolilekas, Andriana I. Papaioannou, Vasilios Tzilas, Argyrios Tzouvelekis, Eva Fouka, Despoina Papakosta, Zoe Daniil, Paschalis Steiropoulos, Athina Gogali, Ilias C. Papanikolaou, Areti Xyfteri, Aggeliki Haritou, Ioanna Korbila, Ioannis P. Tomos, Stylianos Loukides, Rita Bellelli, Georgia Kounti, Christina Rampiadou, Theodoros Karampitsakos, Ilias Dimeas, Paraskevi Kirgou, Andromachi Bompoki, Eirini Vasarmidi, Konstantinos Loverdos, Elvira-Markela Antonogiannaki, Myrto Blizou, Evangelos Bouros, Konstantinos Kagouridis, Maria Maniati, Anna Karakatsani, Katerina M. Antoniou, Effrosyni D. Manali Eur Respir J, 57 (3) 2003111; 10.1183/13993003.03111-2020
PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Joan Truyols, Spain
PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Lea de Maddalena, Switzerland
PP215 – The effect of long-term personal air pollution exposure on the inflammatory mediators in Idiopathic Pulmonary Fibrosis Ioannis Tomos, Greece
PP212 – The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages Carolin Koss, Germany
PP208 – SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis Carmen Veith, Germany
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Victoria Ptasinski, Sweden
PP121 – Gaq/11 and Ga12/13 promote pulmonary fibrosis by driving distinct myofibroblast functions Amanda Goodwin, United Kingdom
Genetic disorders of the surfactant system: focus on adult disease Coline H.M. van Moorsel, Joanne J. van der Vis, Jan C. Grutters Eur Respir Rev, 30 (159) 200085; 10.1183/16000617.0085-2020
“Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study” Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu and Demosthenes Bouros. ERJ Open Res 2020; 6: 00152-2020. ERJ Open Res, 7 (1) 50152-2020; 10.1183/23120541.50152-2020
Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect Teng Moua, Aahd Kubbara, Paul Novotny, Jennifer L. Ridgeway, Andrew H. Limper, Jay H. Ryu, Matthew M. Clark, Roberto Benzo ERJ Open Res, 7 (1) 00011-2021; 10.1183/23120541.00011-2021
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease Michael P. Mohning, Isabelle Amigues, M. Kristen Demoruelle, Evans R. Fernández Pérez, Tristan J. Huie, Rebecca K. Keith, Amy L. Olson, Zulma X. Yunt, Jonathan H. Chung, Stephen Hobbs, Jeffrey J. Swigris, Joshua J. Solomon ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi ERJ Open Res, 7 (1) 00196-2020; 10.1183/23120541.00196-2020
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review Anna-Maria Hoffmann-Vold, Toby M. Maher, Edward E. Philpot, Ali Ashrafzadeh, Oliver Distler ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis Ayodeji Adegunsoye, Julie Morisset, Chad A. Newton, Justin M. Oldham, Eric Vittinghoff, Angela L. Linderholm, Mary E. Strek, Imre Noth, Christine Kim Garcia, Paul J. Wolters, Brett Ley Eur Respir J, 57 (3) 2002872; 10.1183/13993003.02872-2020
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, Melanie Dohmen, Markus C. Brack, Sabrina Schulz, Elisa Thomasch, Szandor Simmons, Holger Müller-Redetzky, Norbert Suttorp, Florian Kurth, Jens Neudecker, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Victor Max Corman, Andreas C. Hocke, Martin Witzenrath, Stefan Hippenstiel, Wolfgang M. Kuebler Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020
Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-? Liv I.B. Sikkeland, Shuo-Wang Qiao, Thor Ueland, Ole Myrdal, Lukasz Wyrozemski, Pål Aukrust, Frode L. Jahnsen, Tone Sjåheim, Johny Kongerud, Øyvind Molberg, May Brit Lund, Espen S. Bækkevold Eur Respir J, 57 (3) 2000983; 10.1183/13993003.00983-2020
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1 Yoshinari Nakatsuka, Ai Yaku, Tomohiro Handa, Alexis Vandenbon, Yuki Hikichi, Yasutaka Motomura, Ayuko Sato, Masanori Yoshinaga, Kiminobu Tanizawa, Kizuku Watanabe, Toyohiro Hirai, Kazuo Chin, Yutaka Suzuki, Takuya Uehata, Takashi Mino, Tohru Tsujimura, Kazuyo Moro, Osamu Takeuchi Eur Respir J, 57 (3) 2000018; 10.1183/13993003.00018-2020
The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis Maria-Pia Di Campli, Abdulkader Azouz, Assiya Assabban, Jessika Scaillet, Marion Splittgerber, Alexandra Van Keymeulen, Frederick Libert, Myriam Remmelink, Alain Le Moine, Philippe Lemaitre, Stanislas Goriely Eur Respir J, 57 (3) 2000344; 10.1183/13993003.00344-2020
Regulation of immune cells in lung fibrosis: the reign of regnase-1? Antoine Froidure, Bruno Crestani Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020
Reply: BAL lymphocyte percentage is as good as the company it keeps Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021
Comment on: Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis Onofre Moran-Mendoza, Mohamed Khalil Eur Respir J, 57 (2) 2004347; 10.1183/13993003.04347-2020
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation Aurélien Justet, Dymph Klay, Raphaël Porcher, Vincent Cottin, Kais Ahmad, Maria Molina Molina, Hilario Nunes, Martine Reynaud-Gaubert, Jean Marc Naccache, Effrosyni Manali, Antoine Froidure, Stéphane Jouneau, Lidwine Wemeau, Claire Andrejak, Anne Gondouin, Sandrine Hirschi, Elodie Blanchard, Benjamin Bondue, Philippe Bonniaud, Cécile Tromeur, Grégoire Prévot, Sylvain Marchand-Adam, Manuela Funke-Chambour, Anne Sophie Gamez, Ibrahima Ba, Spyridon Papiris, Jan Grutters, Bruno Crestani, Coline van Moorsel, Caroline Kannengiesser, Raphaël Borie Eur Respir J, 57 (2) 2003198; 10.1183/13993003.03198-2020
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study) Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, Kaïs Ahmad, Loic Boussel, Marie Brevet, Lara Chalabreysse, Céline Fabre, Sébastien Marque, Didier Revel, Françoise Thivolet-Bejui, Julie Traclet, Sabrina Zeghmar, Delphine Maucort-Boulch, Vincent Cottin Eur Respir J, 57 (2) 2002718; 10.1183/13993003.02718-2020
Methotrexate and rheumatoid arthritis associated interstitial lung disease Pierre-Antoine Juge, Joyce S. Lee, Jessica Lau, Leticia Kawano-Dourado, Jorge Rojas Serrano, Marco Sebastiani, Gouri Koduri, Eric Matteson, Karina Bonfiglioli, Marcio Sawamura, Ronaldo Kairalla, Lorenzo Cavagna, Emanuele Bozzalla Cassione, Andreina Manfredi, Mayra Mejia, Pedro Rodríguez-Henriquez, Montserrat I. González-Pérez, Ramcés Falfán-Valencia, Ivette Buendia-Roldán, Gloria Pérez-Rubio, Esther Ebstein, Steven Gazal, Raphaël Borie, Sébastien Ottaviani, Caroline Kannengiesser, Benoît Wallaert, Yurdagul Uzunhan, Hilario Nunes, Dominique Valeyre, Nathalie Saidenberg-Kermanac'h, Marie-Christophe Boissier, Lidwine Wemeau-Stervinou, René-Marc Flipo, Sylvain Marchand-Adam, Pascal Richette, Yannick Allanore, Claire Dromer, Marie-Elise Truchetet, Christophe Richez, Thierry Schaeverbeke, Huguette Lioté, Gabriel Thabut, Kevin D. Deane, Joshua J. Solomon, Tracy Doyle, Jay H. Ryu, Ivan Rosas, V. Michael Holers, Catherine Boileau, Marie-Pierre Debray, Raphaël Porcher, David A. Schwartz, Robert Vassallo, Bruno Crestani, Philippe Dieudé Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020
The case of methotrexate and the lung: Dr Jekyll and Mr Hyde Vincent Cottin, Elizabeth Bendstrup, Philippe Bonniaud, Mouhamad Nasser, Paolo Spagnolo, Claudia Valenzuela, Martin Kolb Eur Respir J, 57 (2) 2100079; 10.1183/13993003.00079-2021
The cardiovascular system in idiopathic pulmonary fibrosis Sy Giin Chong, Toyoshi Yanagihara, Martin R.J. Kolb Eur Respir Monogr 2020; 88: 198-211
Patients living with other respiratory diseases Arwel W. Jones, Rachel E. Gemine, Syedah Aleena Haider Eur Respir Monogr 2021; 90: 193-207
Interstitial lung disease in welders Martin Paul Cosgrove Eur Respir Monogr 2020; 89: 238-251
Pneumoconiosis and interstitial lung diseases caused by inorganic dust Jennifer Louise Hoyle Eur Respir Monogr 2020; 89: 190-210
Coal mine dust lung disease Leonard H.T. Go, Robert A. Cohen Eur Respir Monogr 2020; 89: 176-189
Silicosis and other silica-related lung disorders Deborah Helwen Yates, Anthony Rutledge Johnson Eur Respir Monogr 2020; 89: 150-175
Asbestosis Kirsten Bennett, Fraser J.H. Brims Eur Respir Monogr 2020; 89: 125-139
Occupational hypersensitivity pneumonitis Christopher Michael Barber, Hayley Barnes Eur Respir Monogr 2020; 89: 104-124
Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis Sabrina Bajwah, Jill Colquitt, Emma Loveman, Claudia Bausewein, Howard Almond, Adejoke Oluyase, Mendy Dzingina, Matthew Maddocks, Irene J. Higginson, Athol Wells ERJ Open Res, 7 (1) 00107-2020; 10.1183/23120541.00107-2020
Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019 Lisa G. Spencer, Maria Loughenbury, Nazia Chaudhuri, Monica Spiteri, Helen Parfrey ERJ Open Res, 7 (1) 00187-2020; 10.1183/23120541.00187-2020
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus Argyris Tzouvelekis, Katerina Antoniou, Michael Kreuter, Matthew Evison, Torsten G. Blum, Venerino Poletti, Bogdan Grigoriu, Carlo Vancheri, Paolo Spagnolo, Theodoros Karampitsakos, Francesco Bonella, Athol Wells, Ganesh Raghu, Maria Molina-Molina, Daniel A. Culver, Elisabeth Bendstrup, Nesrin Mogulkoc, Stefano Elia, Jacques Cadranel, Demosthenes Bouros ERJ Open Res, 7 (1) 00529-2020; 10.1183/23120541.00529-2020
Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact Yuji Yamamoto, Kazuyuki Tsujino, Tomoki Kuge, Fukuko Okabe, Takahiro Kawasaki, Takanori Matsuki, Hiroyuki Kagawa, Mari Miki, Keisuke Miki, Masahide Mori, Hiroshi Kida ERJ Open Res, 7 (1) 00765-2020; 10.1183/23120541.00765-2020
Chronic lung diseases: prospects for regeneration and repair Peter J. Barnes, Gary P. Anderson, Malin Fagerås, Maria G. Belvisi Eur Respir Rev, 30 (159) 200213; 10.1183/16000617.0213-2020
Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients David G. Chapman, Tanya Badal, Gregory G. King, Cindy Thamrin Eur Respir J, 57 (1) 2003263; 10.1183/13993003.03263-2020
Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new Paolo Maria Leone, Luca Richeldi Breathe, 16 (4) 1514; 10.1183/20734735.0223-2020
Pulmonary alveolar microlithiasis Patrick Kosciuk, Cristopher Meyer, Kathryn A. Wikenheiser-Brokamp, Francis X. McCormack Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020
Lung involvement in monogenic interferonopathies Salvatore Cazzato, Alessia Omenetti, Claudia Ravaglia, Venerino Poletti Eur Respir Rev, 29 (158) 200001; 10.1183/16000617.0001-2020
Alveolar proteinosis of genetic origins Alice Hadchouel, David Drummond, Rola Abou Taam, Muriel Lebourgeois, Christophe Delacourt, Jacques de Blic Eur Respir Rev, 29 (158) 190187; 10.1183/16000617.0187-2019
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis Ingrid A. Cox, Nicolas Borchers Arriagada, Barbara de Graaff, Tamera J. Corte, Ian Glaspole, Stella Lartey, E. Haydn Walters, Andrew J. Palmer Eur Respir Rev, 29 (158) 200154; 10.1183/16000617.0154-2020
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis Antoine Froidure, Emmeline Marchal-Duval, Meline Homps-Legrand, Mada Ghanem, Aurélien Justet, Bruno Crestani, Arnaud Mailleux Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019
“Desquamative interstitial pneumonia: a systematic review of its features and outcomes.” Merel E. Hellemons, Catharina C. Moor, Jan von der Thüsen, Mariska Rossius, Arlette Odink, Laila Haugen Thorgersen, Johny Verschakelen, Wim Wuyts, Marlies S. Wijsenbeek and Elisabeth Bendstrup. Eur Respir Rev 2020; 29: 190181. Eur Respir Rev, 29 (157) 190181; 10.1183/16000617.5181-2019
Birt–Hogg–Dubé syndrome Cécile Daccord, Jean-Marc Good, Marie-Anne Morren, Olivier Bonny, Daniel Hohl, Romain Lazor Eur Respir Rev, 29 (157) 200042; 10.1183/16000617.0042-2020
Ultra-rare cystic disease Davide Elia, Olga Torre, Roberto Cassandro, Antonella Caminati, Sergio Harari Eur Respir Rev, 29 (157) 190163; 10.1183/16000617.0163-2019
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review Yet H. Khor, Yvonne Ng, Hayley Barnes, Nicole S.L. Goh, Christine F. McDonald, Anne E. Holland Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019
Fibrotic interstitial lung diseases and air pollution: a systematic literature review Sergio Harari, Ganesh Raghu, Antonella Caminati, Mario Cruciani, Massimo Franchini, Piermannuccio Mannucci Eur Respir Rev, 29 (157) 200093; 10.1183/16000617.0093-2020
Lung complications of Sjogren syndrome Fabrizio Luppi, Marco Sebastiani, Nicola Sverzellati, Alberto Cavazza, Carlo Salvarani, Andreina Manfredi Eur Respir Rev, 29 (157) 200021; 10.1183/16000617.0021-2020
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis Manuela Platé, Delphine Guillotin, Rachel C Chambers Eur Respir Rev, 29 (157) 200269; 10.1183/16000617.0269-2020
Familial hypersensitivity pneumonitis triggered by Cladosporium herbarum exposure during carpooling Thomas Planté-Bordeneuve, Olivier Gilbert, Dominique Latinne, Nicolas Bruffaerts, Benoit Ghaye, Antoine Froidure ERJ Open Res, 6 (3) 00233-2020; 10.1183/23120541.00233-2020
Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial Tessa Schneeberger, Daniela Leitl, Rainer Gloeckl, Inga Jarosch, Daniela Reimann, Wolfgang Hitzl, Rembert Koczulla, Klaus Kenn ERJ Open Res, 6 (3) 00197-2020; 10.1183/23120541.00197-2020
No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis Quentin Le Hingrat, Mada Ghanem, Aurélie Cazes, Benoit Visseaux, Gilles Collin, Diane Descamps, Charlotte Charpentier, Bruno Crestani ERJ Open Res, 6 (3) 00243-2020; 10.1183/23120541.00243-2020
Transbronchial cryobiopsy: an effective tool in the diagnosis of lymphoproliferative disorders of the lung Rita Bianchi, Alessandra Dubini, Silvia Asioli, Claudia Ravaglia, Sara Tomassetti, Silvia Puglisi, Sara Piciucchi, Christian Gurioli, Carlo Gurioli, Roberto Fiocca, Venerino Poletti ERJ Open Res, 6 (3) 00260-2019; 10.1183/23120541.00260-2019
Amyloidosis of the respiratory system: 16 patients with amyloidosis initially diagnosed ante mortem by pulmonologists Masami Yamada, Noboru Takayanagi, Hideaki Yamakawa, Takashi Ishiguro, Tomohisa Baba, Yoshihiko Shimizu, Koji Okudela, Tamiko Takemura, Takashi Ogura ERJ Open Res, 6 (3) 00313-2019; 10.1183/23120541.00313-2019
Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire Tananchai Petnak, Teng Moua ERJ Open Res, 6 (3) 00230-2020; 10.1183/23120541.00230-2020
Pulmonary alveolar microlithiasis: no longer in the stone age Elisabeth Bendstrup, Åsa Lina M. Jönsson ERJ Open Res, 6 (3) 00289-2020; 10.1183/23120541.00289-2020
The association of pulmonary fibrosis with diabetes mellitus Niranjan Jeganathan, Christelle Miot, Airani Sathananthan, Matheni Sathananthan ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis Faria Nasim, Teng Moua ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020
Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study Mukunthan Murthi, Keiichiro Yoshioka, Jeong Hee Cho, Sixto Arias, Elio Danna, Moe Zaw, Greg Holt, Koichiro Tatsumi, Takeshi Kawasaki, Mehdi Mirsaeidi ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease John Odackal, Victor Yu, Diana Gomez-Manjerres, Joshua J. Field, Marie D. Burdick, Borna Mehrad ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020
Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis Jesper Rømhild Davidsen, Lars Christian Lund, Christian B. Laursen, Jesper Hallas, Daniel Pilsgaard Henriksen ERJ Open Res, 6 (4) 00479-2020; 10.1183/23120541.00479-2020
Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros ERJ Open Res, 6 (4) 00152-2020; 10.1183/23120541.00152-2020
Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis Severi Seppälä, Kaisa Rajala, Juho Tuomas Lehto, Eva Sutinen, Laura Mäkitalo, Hannu Kautiainen, Hannu Kankaanranta, Mari Ainola, Tiina Saarto, Marjukka Myllärniemi ERJ Open Res, 6 (4) 00347-2020; 10.1183/23120541.00347-2020
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Yaniv Dotan, William B. Shapiro, Eneida Male, Eduardo C. Dominguez, Amandeep Aneja, Zhao Huaqing, Chandra Dass, Kartik Shenoy, Nathaniel Marchetti, Francis C. Cordova, Gerard J. Criner, A. James Mamary ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly Sheila Ramjug, Jason Weatherald, Sandeep Sahay, Johad Khoury, Vasile Foris, Nagaraj Chandran, Aleksandar Bokan, Laurent Godinas, Marion Delcroix ERJ Open Res, 6 (4) 00304-2020; 10.1183/23120541.00304-2020
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly Clairelyne Dupin, Vânia Fernandes, Fernanda Hernandez-Gonzalez, Sebastiano Emanuele Torrisi, Tiago M. Alfaro, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti ERJ Open Res, 6 (4) 00143-2020; 10.1183/23120541.00143-2020
The adoption of nintedanib in systemic sclerosis: the SENSCIS study Teresa Bruni, Francesco Varone Breathe, 16 (2) e44; 10.1183/20734735.0005-2020
Pulmonary alveolar proteinosis: from classification to therapy Elena Salvaterra, Ilaria Campo Breathe, 16 (2) 215; 10.1183/20734735.0018-2020
Lymphangioleiomyomatosis: a clinical review Anne M. O'Mahony, Evelyn Lynn, David J. Murphy, Aurelie Fabre, Cormac McCarthy Breathe, 16 (2) 1210; 10.1183/20734735.0007-2020
Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need Amanda T. Goodwin, Gauri Saini Breathe, 16 (3) 1176; 10.1183/20734735.0066-2020
Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples Andrea Crespo, Tiago Alfaro, Vivien Somogyi, Michael Kreuter Breathe, 16 (3) e44; 10.1183/20734735.0067-2020